# Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF

> **NCT01687712** · PHASE3 · COMPLETED · sponsor: **Fertility Biotech AG** · enrollment: 1100 (actual)

## Conditions studied

- Infertility

## Interventions

- **DRUG:** AFOLIA
- **DRUG:** Gonal-f® RFF

## Key facts

- **NCT ID:** NCT01687712
- **Lead sponsor:** Fertility Biotech AG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-11-25
- **Primary completion:** 2015-09-10
- **Final completion:** 2016-11-14
- **Target enrollment:** 1100 (ACTUAL)
- **Last updated:** 2017-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01687712

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01687712, "Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01687712. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*